CompletedNCT03619863
ATHN 7: Hemophilia Natural History Study
Studying Hemophilia A
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- American Thrombosis and Hemostasis Network
- Principal Investigator
- Tyler Buckner, MD, MScHemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus
- Enrollment
- 395 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2024
Study locations (29)
- Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital, Phoenix, Arizona, United States
- Orthopaedic Institute for Children HTC, Los Angeles, California, United States
- Orthopedic Institute for Children Hemophilia Program, Los Angeles, California, United States
- Rady Children's Hospital San Diego, San Diego, California, United States
- Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- University of Florida Hemophilia Treatment Center, Gainesville, Florida, United States
- Comprehensive Bleeding Disorders Center at Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Rush University Medical Center, Chicago, Illinois, United States
- Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis, Indiana, United States
- Louisiana Center for Bleeding and Clotting Disorders, Tulane University, New Orleans, Louisiana, United States
- Louisiana Center for Bleeding and Clotting Disorders, New Orleans, Louisiana, United States
- Maine Hemophilia and Thrombosis Center, Scarborough, Maine, United States
- Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center, Boston, Massachusetts, United States
- Michigan State University Center for Bleeding and Clotting Disorders, East Lansing, Michigan, United States
- Children's Mercy Hospital - Kansas City, Kansas City, Missouri, United States
- +14 more locations on ClinicalTrials.gov
Collaborators
Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03619863 on ClinicalTrials.govOther trials for Hemophilia A
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT05936580Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for SurgeryOctapharma
- ACTIVE NOT RECRUITINGNCT07161687A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.Pfizer
- RECRUITINGPHASE4NCT06864975Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)Runhui WU
- RECRUITINGPHASE1NCT06579144Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia ASwedish Orphan Biovitrum
- RECRUITINGPHASE3NCT06738485Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII ProductsCSL Behring
- RECRUITINGNCT06684314A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in TaiwanSanofi
- RECRUITINGNCT07414511Hemophilia A Research ProgramUniversity of Washington
- RECRUITINGEARLY PHASE1NCT06345833Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded StudyUniversity of Minnesota